Recombinant Varicella zoster vaccine (CHO cell) (Lvzhu Biological)

重组水痘带状疱疹疫苗（CHO细胞）(绿竹生物)

Report date: 2025/03/03 16:23:15

Base Information

Drug NameRecombinant Varicella zoster vaccine (CHO cell) (Lvzhu Biological)
Drug Alias NameRecombinant herpes zoster vaccine (Beijing Luzhu Biotechnology)重组水痘带状疱疹病毒疫苗重组带状疱疹疫苗（CHO细胞）LZ-901LZ901
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes ZosterVaricella Zoster Virus InfectionVaccine-Preventable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBeijing Lvzhu Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLvzhu Biopharmaceutical (Zhuhai) Co LtdBeijing Lvzhu Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpes ZosterVaricella Zoster Virus InfectionVaccine-Preventable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A